Detailed answers about LANCASTERCLINIC:ADVANCED PRESCRIBING LIMITED, including incorporation, status, business activity, and accounts information.
When was LANCASTERCLINIC:ADVANCED PRESCRIBING LIMITED founded?
LANCASTERCLINIC:ADVANCED PRESCRIBING LIMITED was officially incorporated on 20 May 2026 and is registered under company number 17233879. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is LANCASTERCLINIC:ADVANCED PRESCRIBING LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of LANCASTERCLINIC:ADVANCED PRESCRIBING LIMITED?
LANCASTERCLINIC:ADVANCED PRESCRIBING LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does LANCASTERCLINIC:ADVANCED PRESCRIBING LIMITED do?
LANCASTERCLINIC:ADVANCED PRESCRIBING LIMITED operates in the following sector: 86220 - Specialists medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is LANCASTERCLINIC:ADVANCED PRESCRIBING LIMITED's registered address?
The registered office address of LANCASTERCLINIC:ADVANCED PRESCRIBING LIMITED is 45 Dutton Drive, Lancaster, England, LA1 3FT. This is the official address filed with Companies House for legal and statutory correspondence.
Is LANCASTERCLINIC:ADVANCED PRESCRIBING LIMITED financially stable?
Financial accounts for LANCASTERCLINIC:ADVANCED PRESCRIBING LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.